Clínic Barcelona
Clínic Barcelona
Research
October 31 2024
Updated findings on dual HER2 inhibition in HER2+ breast cancer
Researchers from the Clínic-IDIBAPS, along with researchers from the Dana Farber Cancer Institute (DFCI) in Boston, have published a review on dual H1